Can DNA injections restore sight?

Article

The injection of DNA into the optic nerve resulted in light perception vision in patients with no light perception and very low vision, according to Sunita Agarwal, MD.

The injection of DNA into the optic nerve resulted in light perception vision in patients with no light perception and very low vision, according to Sunita Agarwal, MD.

Dr Agarwal, from Agarwal's Group of Eye Hospitals, Chennai, India, reported on five patients who have been treated with DNA injections. The DNA was amplified to more than 100 µm by manipulation with an injection of a biotech product (MANA) that was added to the patients' plasma under a microscope.

"This formulation has the advantage of layering on the patient's DNA molecule and amplifying it from a 0.0001 µm particle of DNA in the blood to over 100 µm using MANA. It is not a chemical, pharmaceutical, or an animal product," she explained.

The DNA is picked up using a 5 µm cannula and loaded into a 10 µL syringe with a 33- or 36-gauge needle. The patients who have either no vision or very low vision received intrapapillary injections of the customized MANA through the pars plana into the optic nerve. Dr Agarwal first used this technique in animals a decade ago and progressed to patients five years ago.

Four patients had optic atrophy; three of these had no perception of light and one had hand movement vision near the face. The fifth patient had age-related macular degeneration. Patients were examined 30 minutes after the procedure, for the next 10 days, and one month after the procedure, according to Dr Agarwal.

Of the four cases of the optic nerve disorders, two improved from no light perception to perception of light. One patient remained the same as before the procedure. The patient with hand movement vision near the face progressed to 6/60 vision.

"Amazingly, patients who had had no light perception for a long period gained light perception within seconds and minutes following an injection into the optic nerve," she said. "These injections of DNA showed phenomenal results unparalleled in the history of ophthalmology."

 

Read

ASCRS 2008 meeting highlights.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.